APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Autoimmunity Reagents

Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.

Selected research

Industry Growth & Trends

Global Autoimmunity Reagents Industry Growth and Trends Forecast to 2032

Report ID 173968380128 December 2025116 pages

Choose your research edition.

Industry ResearchAutoimmunity Reagents Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Autoimmunity Reagents Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Autoimmunity Reagents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autoimmunity Reagents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Autoimmunity Reagents Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.

According to the regional perspective, the market of Autoimmunity Reagents can be divided into North America, Europe, Japan, China, etc. in 2019, the market share of Europe is the highest, accounting for about 43%, of which the Asia Pacific region is the main growth pole of the commodity consumption.

EUROIMMUN、HUMAN、Bio-Rad Laboratories are the key manufacturers in the Global Autoimmunity Reagents Production Market. Top 3 totally took up nearly 50% of the global market in 2019, among which EUROIMMUN is the leader with a market share of over 29%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Autoimmunity Reagents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Autoimmunity Reagents market size, estimates, and forecasts are presented in terms of sales volume (K Unit) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Autoimmunity Reagents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Autoimmunity Reagents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Autoimmunity Reagents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Autoimmunity Reagents Market by Company

EUROIMMUN

HUMAN

Bio-Rad Laboratories

AESKU

Inova

MBL

Orgentec

Trinity

Phadia

HOB Biotech

Shenzhen YHLO Biotech

Kangrun Biotech

Immuno-Biological Laboratories

Biomedical diagnostics

Shanghai Kexin

Autoimmunity Reagents Segment by Type

BLOT

ELISA

IFA

CLIA

Autoimmunity Reagents Segment by Application

Hospital

Third-Party Testing Agency

Autoimmunity Reagents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmunity Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autoimmunity Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmunity Reagents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Autoimmunity Reagents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Autoimmunity Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of BLOT Table 2. Major Company of ELISA Table 3. Major Company of IFA Table 4. Major Company of CLIA Table 5. Global Autoimmunity Reagents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Autoimmunity Reagents Sales by Type (2021-2026) & (K Unit) Table 7. Global Autoimmunity Reagents Sales Market Share in Volume by Type (2021-2026) Table 8. Global Autoimmunity Reagents Sales by Type (2021-2026) & (US$ Million) Table 9. Global Autoimmunity Reagents Sales Market Share in Value by Type (2021-2026) Table 10. Global Autoimmunity Reagents Price by Type (2021-2026) & (USD/Unit) Table 11. Global Autoimmunity Reagents Sales by Type (2027-2032) & (K Unit) Table 12. Global Autoimmunity Reagents Sales Market Share in Volume by Type (2027-2032) Table 13. Global Autoimmunity Reagents Sales by Type (2027-2032) & (US$ Million) Table 14. Global Autoimmunity Reagents Sales Market Share in Value by Type (2027-2032) Table 15. Global Autoimmunity Reagents Price by Type (2027-2032) & (USD/Unit) Table 16. North America Autoimmunity Reagents Sales by Type (2021-2026) & (K Unit) Table 17. North America Autoimmunity Reagents Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Autoimmunity Reagents Sales by Type (2021-2026) & (K Unit) Table 19. Europe Autoimmunity Reagents Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Autoimmunity Reagents Sales by Type (2021-2026) & (K Unit) Table 21. Asia-Pacific Autoimmunity Reagents Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Autoimmunity Reagents Sales by Type (2021-2026) & (K Unit) Table 23. Latin America Autoimmunity Reagents Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Autoimmunity Reagents Sales by Type (2021-2026) & (K Unit) Table 25. Middle East and Africa Autoimmunity Reagents Sales by Type (2021-2026) & (US$ Million) Table 26. Autoimmunity Reagents Industry Trends Table 27. Autoimmunity Reagents Industry Drivers Table 28. Autoimmunity Reagents Industry Opportunities and Challenges Table 29. Autoimmunity Reagents Industry Restraints Table 30. Global Autoimmunity Reagents Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Autoimmunity Reagents Revenue Market Share by Company (2021-2026) Table 32. Global Autoimmunity Reagents Sales by Company (2021-2026) & (K Unit) Table 33. Global Autoimmunity Reagents Sales Share by Company (2021-2026) Table 34. Global Autoimmunity Reagents Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Autoimmunity Reagents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Autoimmunity Reagents Major Company Production Sites and Headquarters Table 37. Global Autoimmunity Reagents Company, Product Type & Application Table 38. Global Autoimmunity Reagents Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Autoimmunity Reagents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Autoimmunity Reagents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Autoimmunity Reagents Sales by Region (2021-2026) & (K Unit) Table 43. Global Autoimmunity Reagents Sales Market Share in Volume by Region (2021-2026) Table 44. Global Autoimmunity Reagents Sales by Region (2021-2026) & (US$ Million) Table 45. Global Autoimmunity Reagents Sales Market Share in Value by Region (2021-2026) Table 46. Global Autoimmunity Reagents Sales (K Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Autoimmunity Reagents Sales by Region (2027-2032) & (K Unit) Table 48. Global Autoimmunity Reagents Sales Market Share in Volume by Region (2027-2032) Table 49. Global Autoimmunity Reagents Sales by Region (2027-2032) & (US$ Million) Table 50. Global Autoimmunity Reagents Sales Market Share in Value by Region (2027-2032) Table 51. Global Autoimmunity Reagents Sales (K Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Autoimmunity Reagents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Autoimmunity Reagents Sales by Application (2021-2026) & (K Unit) Table 54. Global Autoimmunity Reagents Sales Market Share in Volume by Application (2021-2026) Table 55. Global Autoimmunity Reagents Sales by Application (2021-2026) & (US$ Million) Table 56. Global Autoimmunity Reagents Sales Market Share in Value by Application (2021-2026) Table 57. Global Autoimmunity Reagents Price by Application (2021-2026) & (USD/Unit) Table 58. Global Autoimmunity Reagents Sales by Application (2027-2032) & (K Unit) Table 59. Global Autoimmunity Reagents Sales Market Share in Volume by Application (2027-2032) Table 60. Global Autoimmunity Reagents Sales by Application (2027-2032) & (US$ Million) Table 61. Global Autoimmunity Reagents Sales Market Share in Value by Application (2027-2032) Table 62. Global Autoimmunity Reagents Price by Application (2027-2032) & (USD/Unit) Table 63. North America Autoimmunity Reagents Sales by Application (2021-2026) & (K Unit) Table 64. North America Autoimmunity Reagents Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Autoimmunity Reagents Sales by Application (2021-2026) & (K Unit) Table 66. Europe Autoimmunity Reagents Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Autoimmunity Reagents Sales by Application (2021-2026) & (K Unit) Table 68. Asia-Pacific Autoimmunity Reagents Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Autoimmunity Reagents Sales by Application (2021-2026) & (K Unit) Table 70. Latin America Autoimmunity Reagents Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Autoimmunity Reagents Sales by Application (2021-2026) & (K Unit) Table 72. Middle East and Africa Autoimmunity Reagents Sales by Application (2021-2026) & (US$ Million) Table 73. EUROIMMUN Company Information Table 74. EUROIMMUN Business Overview Table 75. EUROIMMUN Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. EUROIMMUN Autoimmunity Reagents Product Portfolio Table 77. EUROIMMUN Recent Development Table 78. HUMAN Company Information Table 79. HUMAN Business Overview Table 80. HUMAN Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. HUMAN Autoimmunity Reagents Product Portfolio Table 82. HUMAN Recent Development Table 83. Bio-Rad Laboratories Company Information Table 84. Bio-Rad Laboratories Business Overview Table 85. Bio-Rad Laboratories Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Bio-Rad Laboratories Autoimmunity Reagents Product Portfolio Table 87. Bio-Rad Laboratories Recent Development Table 88. AESKU Company Information Table 89. AESKU Business Overview Table 90. AESKU Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. AESKU Autoimmunity Reagents Product Portfolio Table 92. AESKU Recent Development Table 93. Inova Company Information Table 94. Inova Business Overview Table 95. Inova Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Inova Autoimmunity Reagents Product Portfolio Table 97. Inova Recent Development Table 98. MBL Company Information Table 99. MBL Business Overview Table 100. MBL Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. MBL Autoimmunity Reagents Product Portfolio Table 102. MBL Recent Development Table 103. Orgentec Company Information Table 104. Orgentec Business Overview Table 105. Orgentec Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Orgentec Autoimmunity Reagents Product Portfolio Table 107. Orgentec Recent Development Table 108. Trinity Company Information Table 109. Trinity Business Overview Table 110. Trinity Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Trinity Autoimmunity Reagents Product Portfolio Table 112. Trinity Recent Development Table 113. Phadia Company Information Table 114. Phadia Business Overview Table 115. Phadia Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Phadia Autoimmunity Reagents Product Portfolio Table 117. Phadia Recent Development Table 118. HOB Biotech Company Information Table 119. HOB Biotech Business Overview Table 120. HOB Biotech Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. HOB Biotech Autoimmunity Reagents Product Portfolio Table 122. HOB Biotech Recent Development Table 123. Shenzhen YHLO Biotech Company Information Table 124. Shenzhen YHLO Biotech Business Overview Table 125. Shenzhen YHLO Biotech Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolio Table 127. Shenzhen YHLO Biotech Recent Development Table 128. Kangrun Biotech Company Information Table 129. Kangrun Biotech Business Overview Table 130. Kangrun Biotech Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Kangrun Biotech Autoimmunity Reagents Product Portfolio Table 132. Kangrun Biotech Recent Development Table 133. Immuno-Biological Laboratories Company Information Table 134. Immuno-Biological Laboratories Business Overview Table 135. Immuno-Biological Laboratories Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolio Table 137. Immuno-Biological Laboratories Recent Development Table 138. Biomedical diagnostics Company Information Table 139. Biomedical diagnostics Business Overview Table 140. Biomedical diagnostics Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. Biomedical diagnostics Autoimmunity Reagents Product Portfolio Table 142. Biomedical diagnostics Recent Development Table 143. Shanghai Kexin Company Information Table 144. Shanghai Kexin Business Overview Table 145. Shanghai Kexin Autoimmunity Reagents Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 146. Shanghai Kexin Autoimmunity Reagents Product Portfolio Table 147. Shanghai Kexin Recent Development Table 148. North America Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country (K Unit): 2021 VS 2025 VS 2032 Table 149. North America Autoimmunity Reagents Sales by Country (2021-2026) & (K Unit) Table 150. North America Autoimmunity Reagents Sales Market Share by Country (2021-2026) Table 151. North America Autoimmunity Reagents Sales Forecast by Country (2027-2032) & (K Unit) Table 152. North America Autoimmunity Reagents Sales Market Share Forecast by Country (2027-2032) Table 153. North America Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Autoimmunity Reagents Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Autoimmunity Reagents Market Share by Country (2021-2026) Table 156. North America Autoimmunity Reagents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Autoimmunity Reagents Market Share Forecast by Country (2027-2032) Table 158. Europe Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country (K Unit): 2021 VS 2025 VS 2032 Table 159. Europe Autoimmunity Reagents Sales by Country (2021-2026) & (K Unit) Table 160. Europe Autoimmunity Reagents Sales Market Share by Country (2021-2026) Table 161. Europe Autoimmunity Reagents Sales Forecast by Country (2027-2032) & (K Unit) Table 162. Europe Autoimmunity Reagents Sales Market Share Forecast by Country (2027-2032) Table 163. Europe Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Autoimmunity Reagents Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Autoimmunity Reagents Market Share by Country (2021-2026) Table 166. Europe Autoimmunity Reagents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Autoimmunity Reagents Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country (K Unit): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Autoimmunity Reagents Sales by Country (2021-2026) & (K Unit) Table 170. Asia-Pacific Autoimmunity Reagents Sales Market Share by Country (2021-2026) Table 171. Asia-Pacific Autoimmunity Reagents Sales Forecast by Country (2027-2032) & (K Unit) Table 172. Asia-Pacific Autoimmunity Reagents Sales Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Autoimmunity Reagents Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Autoimmunity Reagents Market Share by Country (2021-2026) Table 176. Asia-Pacific Autoimmunity Reagents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Autoimmunity Reagents Market Share Forecast by Country (2027-2032) Table 178. Latin America Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country (K Unit): 2021 VS 2025 VS 2032 Table 179. Latin America Autoimmunity Reagents Sales by Country (2021-2026) & (K Unit) Table 180. Latin America Autoimmunity Reagents Sales Market Share by Country (2021-2026) Table 181. Latin America Autoimmunity Reagents Sales Forecast by Country (2027-2032) & (K Unit) Table 182. Latin America Autoimmunity Reagents Sales Market Share Forecast by Country (2027-2032) Table 183. Latin America Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Autoimmunity Reagents Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Autoimmunity Reagents Market Share by Country (2021-2026) Table 186. Latin America Autoimmunity Reagents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Autoimmunity Reagents Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country (K Unit): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Autoimmunity Reagents Sales by Country (2021-2026) & (K Unit) Table 190. Middle East and Africa Autoimmunity Reagents Sales Market Share by Country (2021-2026) Table 191. Middle East and Africa Autoimmunity Reagents Sales Forecast by Country (2027-2032) & (K Unit) Table 192. Middle East and Africa Autoimmunity Reagents Sales Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Autoimmunity Reagents Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East and Africa Autoimmunity Reagents Market Share by Country (2021-2026) Table 196. Middle East and Africa Autoimmunity Reagents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East and Africa Autoimmunity Reagents Market Share Forecast by Country (2027-2032) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Autoimmunity Reagents Distributors List Table 201. Autoimmunity Reagents Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Autoimmunity Reagents Image Figure 2. Global Autoimmunity Reagents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Autoimmunity Reagents Market Size (2021-2032) & (US$ Million) Figure 4. Global Autoimmunity Reagents Sales (2021-2032) & (K Unit) Figure 5. BLOT Image Figure 6. Global BLOT Sales YoY Growth (2021-2032) & (K Unit) Figure 7. ELISA Image Figure 8. Global ELISA Sales YoY Growth (2021-2032) & (K Unit) Figure 9. IFA Image Figure 10. Global IFA Sales YoY Growth (2021-2032) & (K Unit) Figure 11. CLIA Image Figure 12. Global CLIA Sales YoY Growth (2021-2032) & (K Unit) Figure 13. Global Autoimmunity Reagents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Autoimmunity Reagents Market Share by Type 2025 VS 2032 Figure 15. North America Autoimmunity Reagents Sales Market Share in Volume by Type in 2025 Figure 16. North America Autoimmunity Reagents Sales Market Share in Value by Type in 2025 Figure 17. Europe Autoimmunity Reagents Sales Market Share in Volume by Type in 2025 Figure 18. Europe Autoimmunity Reagents Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Autoimmunity Reagents Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Autoimmunity Reagents Sales Market Share in Value by Type in 2025 Figure 21. Latin America Autoimmunity Reagents Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Autoimmunity Reagents Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Autoimmunity Reagents Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Autoimmunity Reagents Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Autoimmunity Reagents Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Unit) Figure 29. Third-Party Testing Agency Image Figure 30. Global Third-Party Testing Agency Sales YoY Growth (2021-2032) & (K Unit) Figure 31. Global Autoimmunity Reagents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Autoimmunity Reagents Market Share by Application 2025 VS 2032 Figure 33. North America Autoimmunity Reagents Sales Market Share in Volume by Application in 2025 Figure 34. North America Autoimmunity Reagents Sales Market Share in Value by Application in 2025 Figure 35. Europe Autoimmunity Reagents Sales Market Share in Volume by Application in 2025 Figure 36. Europe Autoimmunity Reagents Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Autoimmunity Reagents Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Autoimmunity Reagents Sales Market Share in Value by Application in 2025 Figure 39. Latin America Autoimmunity Reagents Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Autoimmunity Reagents Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Autoimmunity Reagents Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Autoimmunity Reagents Sales Market Share in Value by Application in 2025 Figure 43. North America Autoimmunity Reagents Sales by Country: 2021 VS 2025 VS 2032 (K Unit) Figure 44. North America Autoimmunity Reagents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Autoimmunity Reagents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Autoimmunity Reagents Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Autoimmunity Reagents Sales by Country: 2021 VS 2025 VS 2032 (K Unit) Figure 48. Europe Autoimmunity Reagents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Autoimmunity Reagents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Autoimmunity Reagents Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Autoimmunity Reagents Sales by Country: 2021 VS 2025 VS 2032 (K Unit) Figure 52. Asia-Pacific Autoimmunity Reagents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Autoimmunity Reagents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Autoimmunity Reagents Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Autoimmunity Reagents Sales by Country: 2021 VS 2025 VS 2032 (K Unit) Figure 56. Latin America Autoimmunity Reagents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Autoimmunity Reagents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Autoimmunity Reagents Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Autoimmunity Reagents Sales by Country: 2021 VS 2025 VS 2032 (K Unit) Figure 60. Middle East and Africa Autoimmunity Reagents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Autoimmunity Reagents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Autoimmunity Reagents Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Autoimmunity Reagents Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Autoimmunity Reagents Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • BLOT
  • ELISA
  • IFA
  • CLIA
Applications
  • Hospital
  • Third-Party Testing Agency
Companies covered
  • EUROIMMUN
  • HUMAN
  • Bio-Rad Laboratories
  • AESKU
  • Inova
  • MBL
  • Orgentec
  • Trinity
  • Phadia
  • HOB Biotech
  • Shenzhen YHLO Biotech
  • Kangrun Biotech
  • Immuno-Biological Laboratories
  • Biomedical diagnostics
  • Shanghai Kexin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Autoimmunity Reagents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Autoimmunity Reagents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Autoimmunity Reagents Market by Type
  6. 1.3.1 BLOT
  7. 1.3.2 ELISA
  8. 1.3.3 IFA
  9. 1.3.4 CLIA
  10. 1.4 Global Autoimmunity Reagents Market Size by Type
  11. 1.4.1 Global Autoimmunity Reagents Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Autoimmunity Reagents Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Autoimmunity Reagents Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Autoimmunity Reagents Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Autoimmunity Reagents Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Autoimmunity Reagents Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Autoimmunity Reagents Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Autoimmunity Reagents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Autoimmunity Reagents Industry Trends
  2. 2.2 Autoimmunity Reagents Industry Drivers
  3. 2.3 Autoimmunity Reagents Industry Opportunities and Challenges
  4. 2.4 Autoimmunity Reagents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Autoimmunity Reagents Revenue (2021-2026)
  2. 3.2 Global Top Players by Autoimmunity Reagents Sales (2021-2026)
  3. 3.3 Global Top Players by Autoimmunity Reagents Price (2021-2026)
  4. 3.4 Global Autoimmunity Reagents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Autoimmunity Reagents Major Company Production Sites & Headquarters
  6. 3.6 Global Autoimmunity Reagents Company, Product Type & Application
  7. 3.7 Global Autoimmunity Reagents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Autoimmunity Reagents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Autoimmunity Reagents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Autoimmunity Reagents Tier 1, Tier 2, and Tier 3
4 Autoimmunity Reagents Regional Status and Outlook
  1. 4.1 Global Autoimmunity Reagents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Autoimmunity Reagents Historic Market Size by Region
  3. 4.2.1 Global Autoimmunity Reagents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Autoimmunity Reagents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Autoimmunity Reagents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Autoimmunity Reagents Forecasted Market Size by Region
  7. 4.3.1 Global Autoimmunity Reagents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Autoimmunity Reagents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Autoimmunity Reagents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Autoimmunity Reagents by Application
  1. 5.1 Autoimmunity Reagents Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Third-Party Testing Agency
  4. 5.2 Global Autoimmunity Reagents Market Size by Application
  5. 5.2.1 Global Autoimmunity Reagents Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Autoimmunity Reagents Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Autoimmunity Reagents Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Autoimmunity Reagents Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Autoimmunity Reagents Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Autoimmunity Reagents Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Autoimmunity Reagents Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Autoimmunity Reagents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 EUROIMMUN
  2. 6.1.1 EUROIMMUN Company Information
  3. 6.1.2 EUROIMMUN Business Overview
  4. 6.1.3 EUROIMMUN Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 EUROIMMUN Autoimmunity Reagents Product Portfolio
  6. 6.1.5 EUROIMMUN Recent Developments
  7. 6.2 HUMAN
  8. 6.2.1 HUMAN Company Information
  9. 6.2.2 HUMAN Business Overview
  10. 6.2.3 HUMAN Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 HUMAN Autoimmunity Reagents Product Portfolio
  12. 6.2.5 HUMAN Recent Developments
  13. 6.3 Bio-Rad Laboratories
  14. 6.3.1 Bio-Rad Laboratories Company Information
  15. 6.3.2 Bio-Rad Laboratories Business Overview
  16. 6.3.3 Bio-Rad Laboratories Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bio-Rad Laboratories Autoimmunity Reagents Product Portfolio
  18. 6.3.5 Bio-Rad Laboratories Recent Developments
  19. 6.4 AESKU
  20. 6.4.1 AESKU Company Information
  21. 6.4.2 AESKU Business Overview
  22. 6.4.3 AESKU Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AESKU Autoimmunity Reagents Product Portfolio
  24. 6.4.5 AESKU Recent Developments
  25. 6.5 Inova
  26. 6.5.1 Inova Company Information
  27. 6.5.2 Inova Business Overview
  28. 6.5.3 Inova Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Inova Autoimmunity Reagents Product Portfolio
  30. 6.5.5 Inova Recent Developments
  31. 6.6 MBL
  32. 6.6.1 MBL Company Information
  33. 6.6.2 MBL Business Overview
  34. 6.6.3 MBL Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 MBL Autoimmunity Reagents Product Portfolio
  36. 6.6.5 MBL Recent Developments
  37. 6.7 Orgentec
  38. 6.7.1 Orgentec Company Information
  39. 6.7.2 Orgentec Business Overview
  40. 6.7.3 Orgentec Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Orgentec Autoimmunity Reagents Product Portfolio
  42. 6.7.5 Orgentec Recent Developments
  43. 6.8 Trinity
  44. 6.8.1 Trinity Company Information
  45. 6.8.2 Trinity Business Overview
  46. 6.8.3 Trinity Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Trinity Autoimmunity Reagents Product Portfolio
  48. 6.8.5 Trinity Recent Developments
  49. 6.9 Phadia
  50. 6.9.1 Phadia Company Information
  51. 6.9.2 Phadia Business Overview
  52. 6.9.3 Phadia Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Phadia Autoimmunity Reagents Product Portfolio
  54. 6.9.5 Phadia Recent Developments
  55. 6.10 HOB Biotech
  56. 6.10.1 HOB Biotech Company Information
  57. 6.10.2 HOB Biotech Business Overview
  58. 6.10.3 HOB Biotech Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 HOB Biotech Autoimmunity Reagents Product Portfolio
  60. 6.10.5 HOB Biotech Recent Developments
  61. 6.11 Shenzhen YHLO Biotech
  62. 6.11.1 Shenzhen YHLO Biotech Company Information
  63. 6.11.2 Shenzhen YHLO Biotech Business Overview
  64. 6.11.3 Shenzhen YHLO Biotech Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolio
  66. 6.11.5 Shenzhen YHLO Biotech Recent Developments
  67. 6.12 Kangrun Biotech
  68. 6.12.1 Kangrun Biotech Company Information
  69. 6.12.2 Kangrun Biotech Business Overview
  70. 6.12.3 Kangrun Biotech Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Kangrun Biotech Autoimmunity Reagents Product Portfolio
  72. 6.12.5 Kangrun Biotech Recent Developments
  73. 6.13 Immuno-Biological Laboratories
  74. 6.13.1 Immuno-Biological Laboratories Company Information
  75. 6.13.2 Immuno-Biological Laboratories Business Overview
  76. 6.13.3 Immuno-Biological Laboratories Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolio
  78. 6.13.5 Immuno-Biological Laboratories Recent Developments
  79. 6.14 Biomedical diagnostics
  80. 6.14.1 Biomedical diagnostics Company Information
  81. 6.14.2 Biomedical diagnostics Business Overview
  82. 6.14.3 Biomedical diagnostics Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Biomedical diagnostics Autoimmunity Reagents Product Portfolio
  84. 6.14.5 Biomedical diagnostics Recent Developments
  85. 6.15 Shanghai Kexin
  86. 6.15.1 Shanghai Kexin Company Information
  87. 6.15.2 Shanghai Kexin Business Overview
  88. 6.15.3 Shanghai Kexin Autoimmunity Reagents Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Shanghai Kexin Autoimmunity Reagents Product Portfolio
  90. 6.15.5 Shanghai Kexin Recent Developments
7 North America by Country
  1. 7.1 North America Autoimmunity Reagents Sales by Country
  2. 7.1.1 North America Autoimmunity Reagents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Autoimmunity Reagents Sales by Country (2021-2026)
  4. 7.1.3 North America Autoimmunity Reagents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Autoimmunity Reagents Market Size by Country
  6. 7.2.1 North America Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Autoimmunity Reagents Market Size by Country (2021-2026)
  8. 7.2.3 North America Autoimmunity Reagents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Autoimmunity Reagents Sales by Country
  2. 8.1.1 Europe Autoimmunity Reagents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Autoimmunity Reagents Sales by Country (2021-2026)
  4. 8.1.3 Europe Autoimmunity Reagents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Autoimmunity Reagents Market Size by Country
  6. 8.2.1 Europe Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Autoimmunity Reagents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Autoimmunity Reagents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Autoimmunity Reagents Sales by Country
  2. 9.1.1 Asia-Pacific Autoimmunity Reagents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Autoimmunity Reagents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Autoimmunity Reagents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Autoimmunity Reagents Market Size by Country
  6. 9.2.1 Asia-Pacific Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Autoimmunity Reagents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Autoimmunity Reagents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Autoimmunity Reagents Sales by Country
  2. 10.1.1 South America Autoimmunity Reagents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Autoimmunity Reagents Sales by Country (2021-2026)
  4. 10.1.3 South America Autoimmunity Reagents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Autoimmunity Reagents Market Size by Country
  6. 10.2.1 South America Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Autoimmunity Reagents Market Size by Country (2021-2026)
  8. 10.2.3 South America Autoimmunity Reagents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Autoimmunity Reagents Sales by Country
  2. 11.1.1 Middle East and Africa Autoimmunity Reagents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Autoimmunity Reagents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Autoimmunity Reagents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Autoimmunity Reagents Market Size by Country
  6. 11.2.1 Middle East and Africa Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Autoimmunity Reagents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Autoimmunity Reagents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Autoimmunity Reagents Value Chain Analysis
  2. 12.1.1 Autoimmunity Reagents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Autoimmunity Reagents Production Mode & Process
  7. 12.2 Autoimmunity Reagents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Autoimmunity Reagents Distributors
  10. 12.2.3 Autoimmunity Reagents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst